Neuraxis to present at oppenheimer 34th annual healthcare medtech & services conference

Carmel, ind., feb. 27, 2024 (globe newswire) -- neuraxis, inc. (nyse american: nrxs), (“neuraxis,” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that president and chief executive officer brian carrico and chief medical officer dr. adrian miranda, will participate in the upcoming oppenheimer 34th annual healthcare medtech & services conference on march 12, 2024.
NRXS Ratings Summary
NRXS Quant Ranking